Literature DB >> 24893876

Oxidative stress modulates the expression of genes involved in cell survival in ΔF508 cystic fibrosis airway epithelial cells.

Grégory Voisin1, Guillaume F Bouvet2, Pierre Legendre3, André Dagenais2, Chantal Massé2, Yves Berthiaume4.   

Abstract

Although cystic fibrosis (CF) pathophysiology is explained by a defect in CF transmembrane conductance regulator (CFTR) protein, the broad spectrum of disease severity is the consequence of environmental and genetic factors. Among them, oxidative stress has been demonstrated to play an important role in the evolution of this disease, with susceptibility to oxidative damage, decline of pulmonary function, and impaired lung antioxidant defense. Although oxidative stress has been implicated in the regulation of inflammation, its molecular outcomes in CF cells remain to be evaluated. To address the question, we compared the gene expression profile in NuLi-1 cells with wild-type CFTR and CuFi-1 cells homozygous for ΔF508 mutation cultured at air-liquid interface. We analyzed the transcriptomic response of these cell lines with microarray technology, under basal culture conditions and after 24 h oxidative stress induced by 15 μM 2,3-dimethoxy-1,4-naphtoquinone. In the absence of oxidative conditions, CuFi-1 gene profiling showed typical dysregulated inflammatory responses compared with NuLi-1. In the presence of oxidative conditions, the transcriptome of CuFi-1 cells reflected apoptotic transcript modulation. These results were confirmed in the CFBE41o- and corrCFBE41o- cell lines as well as in primary culture of human CF airway epithelial cells. Altogether, our data point to the influence of oxidative stress on cell survival functions in CF and identify several genes that could be implicated in the inflammation response observed in CF patients.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  apoptosis; cystic fibrosis; microarray; oxidative stress; two-way permutational multivariate analysis of variance; ΔF508

Mesh:

Substances:

Year:  2014        PMID: 24893876     DOI: 10.1152/physiolgenomics.00003.2014

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  9 in total

1.  Junctional abnormalities in human airway epithelial cells expressing F508del CFTR.

Authors:  Samuel A Molina; Brandon Stauffer; Hannah K Moriarty; Agnes H Kim; Nael A McCarty; Michael Koval
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-26       Impact factor: 5.464

2.  Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-04-29

3.  The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.

Authors:  Antonietta Santoro; Elena Ciaglia; Vanessa Nicolin; Alessandra Pescatore; Lucia Prota; Mario Capunzo; Matilde V Ursini; Stefania L Nori; Maurizio Bifulco
Journal:  Inflamm Res       Date:  2017-12-11       Impact factor: 4.575

Review 4.  Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights.

Authors:  Justin E Ideozu; Xi Zhang; Susanna McColley; Hara Levy
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

5.  SARS-CoV-2 (COVID-19) and cystic fibrosis.

Authors:  Bruce A Stanton; Thomas H Hampton; Alix Ashare
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-15       Impact factor: 5.464

Review 6.  The Impact of Air Pollution on the Course of Cystic Fibrosis: A Review.

Authors:  Marion Blayac; Patrice Coll; Valérie Urbach; Pascale Fanen; Ralph Epaud; Sophie Lanone
Journal:  Front Physiol       Date:  2022-06-02       Impact factor: 4.755

7.  Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic.

Authors:  Giulia Baresi; Mauro Giacomelli; Daniele Moratto; Marco Chiarini; Immacolata Claudia Conforti; Rita Padoan; Piercarlo Poli; Silviana Timpano; Francesca Caldarale; Raffaele Badolato
Journal:  Front Pediatr       Date:  2021-07-06       Impact factor: 3.418

Review 8.  Sars-CoV-2 infection in patients with cystic fibrosis. An overview.

Authors:  Valentina Fainardi; Francesco Longo; Alfredo Chetta; Susanna Esposito; Giovanna Pisi
Journal:  Acta Biomed       Date:  2020-09-07

9.  Copper-Associated Oxidative Stress Contributes to Cellular Inflammatory Responses in Cystic Fibrosis.

Authors:  Amal Kouadri; Johanna Cormenier; Kevin Gemy; Laurence Macari; Peggy Charbonnier; Pierre Richaud; Isabelle Michaud-Soret; Nadia Alfaidy; Mohamed Benharouga
Journal:  Biomedicines       Date:  2021-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.